SCHEMBL18993700

SCHEMBL18993700

CCCCNc1cc(C(=O)O)cc(NCc2cccnc2)c1Oc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.59
▸ KDM4E B2RXH2 2/20 0.59
▸ TSHR P16473 2/20 0.59
▸ USP2 O75604 1/20 0.59
▸ CA2 P00918 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ HPGD P15428 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ SLC12A2 P55011 1/20 0.59
▸ HIF1A Q16665 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ HSD17B10 Q99714 1/20 0.59
▸ AQP1 P29972 1/20 0.51
▸ PTGS2 P35354 3/20 0.45
▸ KDM4C Q9H3R0 2/20 0.45
▸ KDM6B O15054 1/20 0.45
▸ NAMPT P43490 1/20 0.44
▸ VNN1 O95497 1/20 0.43
▸ MMP13 P45452 1/20 0.42
▸ TRPV1 Q8NER1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741873 0.90 CA2 (0.68) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL18993679 0.86 ALDH1A1 (0.46) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL19300068 0.82 HPGD (0.61) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL2741867 0.82 KDM4E (0.72) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL18993636 0.81 ALDH1A1 (0.60) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL2741865 0.81 KDM4E (0.71) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL12508001 0.81 AQP1 (0.70) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL29496263 0.81 AQP1 (0.70) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL2875002 0.80 KDM4E (0.69) ALDH1A1KDM4ETSHRUSP2CA2
SCHEMBL2741864 0.80 ALDH1A1 (0.69) ALDH1A1KDM4ETSHRUSP2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682928-B2 Bumetanide analogs, compositions and methods of use NEUROPRO THERAPEUTICS, INC. (US) 2017-06-20 — — US disclosed
Send feedback